In this episode, Dr. Brad Thompson returns to discuss success in the field of oncology, fighting cancer tumors with proprietary Reolysin technology with 1100 patients treated to date via his company Oncolytics Biotech (SHGT) ...
Join Ellis Martin for an interview with Kenneth Efird of Nobilis Health Corp, trading on the NYSE as HLTH and on the Toronto Stock Exchange as NHC. Nobilis owns and manages ambulatory and acute care facilities to deliver heal...
In this episode David Morgan of The Morgan Report says these are the good old days and we've reached a standard of living top that must come down. Bob Lange opines on Steven Chen's company, Success Holding Group International...
In this episode David Morgan of The Morgan Report says these are the good old days and we've reached a standard of living top that must come down. Bob Lange opines on Steven Chen's company, Success Holding Group International...
On this week’s program Ellis Martin speaks with Micheal Skerry, an investor with Success Holding Group International, trading on the OTCQB under the symbol SHGT. SHGT is founded by Steve Chen, Asia’s number one motivational s...
On this week’s program Ellis speaks with Micheal Skerry, an investor with Success Holding Group International, trading on the OTCQB under the symbol SHGT. SHGT is founded by Steve Chen, Asia’s number one motivational speaker ...
In this episode of The Ellis Martin report David Morgan reveals a new technology to portably mill gold on a mine site freeing up potential cash. Dudley Baker and Ellis Martin spar about the viability of $900-$1000/ounce gold ...
In this episode join Ellis for a look at Success Holding trading as SHGT on the OTCBB and their founder Steve Chen, Asia's top motivational speaker with over 80 million followers. Dr. Brad Thompson of Oncolytics Biotech (ONCY...
In this episode join Ellis for a look at Success Holding trading as SHGT on the OTCBB and their founder Steve Chen, Asia's top motivational speaker with over 80 million followers. Dr. Brad Thompson of Oncolytics Biotech (ONCY...
In this episode of The Ellis Martin Report, join Ellis for a conversation with TheRavingCapitalist.com. Paul Mladjenovic. He’s concerned about world economic woes and he’s cautioning us about the next few months. Dudley Baker...
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of...
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of...
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of...
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of...
Dr. Brad Thompson, President of Oncolytics Biotech Inc. (NASDAQ:ONCY/TSX:ONC) Oncolytics Biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of...
Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leavi...
Today on the program Ellis speaks with Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors while leavi...
On this program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumors wh...
Today on the program Ellis speaks with a new sponsor Brad Thompson, CEO of Oncolytics Biotech Inc. trading as ONCY on the NASDAQ and ONC on the TSX. Oncolytics has developed a REOVIRUS called REOLYSIN that attacks cancer tumo...
In this episode Ellis speaks with Greg Johnson, CEO of Wellgreen Platinum (TSX:WG) about the Wellgreen PGM Project in the Canadian Yukon Territory. Ellis then chats with several of the principles of Nobilis Health based in Ho...
On this week’s show Ellis speaks with the President of Wellgreen Platinum, Greg Johnson. Wellgreen trades on the TSX as WG and on the OTCQX as WGPLF. Wellgreen has just released their 2015 Preliminary Economic Assessment Repo...
On this week’s show Ellis speaks with the President of Wellgreen Platinum, Greg Johnson. Wellgreen trades on the TSX as WG and on the OTCQX as WGPLF. Wellgreen has just released their 2015 Preliminary Economic Assessment Repo...
On this week’s program Ellis visits with Dr. Don Kramer, Chairman of Nobilis Health, trading on the TSX as NHC up almost double since they began on this program in early January. Next we’ll hear from Greg Johnson, President o...